상세 보기

최주환 프로필 사진

최주환

Choi, Ju Whan

연도별 연구 활동 현황

전체 73건 중 51번부터 60번까지의 결과를 표시합니다.

2022

Article

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors

2021

Article

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

Article

Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D-LCO) and forced expiratory volume in one second (FEV1)

Conference

KUgliptin, a Novel and Potent DPP4 Inhibitor, Improves of Combined Therapy with Immune Checkpoint Inhibitor (ICI) in Lung Cancer Immunotherapy

Article

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

2020

Conference

A Case of Pulmonary Langerhans Cell Histiocytosis Treated with Glucocorticoid Therapy: Focus on Radiologic Findings from Early Stage to Late Stage

Article

Relationship between Particulate Matter (PM10) and Airway Inflammation Measured with Exhaled Nitric Oxide Test in Seoul, Korea

Article

Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study

Article

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors

2019

Conference

PET CT might be better than CT scan when evaluating immune checkpoint inhibitor response.

상세 보기

최주환

자료유형

발행연도

키워드

언어

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D-LCO) and forced expiratory volume in one second (FEV1)

KUgliptin, a Novel and Potent DPP4 Inhibitor, Improves of Combined Therapy with Immune Checkpoint Inhibitor (ICI) in Lung Cancer Immunotherapy

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

A Case of Pulmonary Langerhans Cell Histiocytosis Treated with Glucocorticoid Therapy: Focus on Radiologic Findings from Early Stage to Late Stage

Relationship between Particulate Matter (PM10) and Airway Inflammation Measured with Exhaled Nitric Oxide Test in Seoul, Korea

Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors

PET CT might be better than CT scan when evaluating immune checkpoint inhibitor response.